SUPPORTIVE USE

The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.

Saved in:
Bibliographic Details
Main Authors TERJE KALLAND, BO NILSSON, BIRGITTA TERMANDER
Format Patent
LanguageEnglish
Published 21.10.1991
Edition5
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.
Bibliography:Application Number: AU19910075623